182 related articles for article (PubMed ID: 21821378)
1. Patterns in admission delays to outpatient methadone treatment in the United States.
Gryczynski J; Schwartz RP; Salkever DS; Mitchell SG; Jaffe JH
J Subst Abuse Treat; 2011 Dec; 41(4):431-9. PubMed ID: 21821378
[TBL] [Abstract][Full Text] [Related]
2. Responses among substance abuse treatment providers to the opioid epidemic in the USA: Variations in buprenorphine and methadone treatment by geography, operational, and payment characteristics, 2007-16.
Yang JC; Roman-Urrestarazu A; Brayne C
PLoS One; 2020; 15(3):e0229787. PubMed ID: 32126120
[TBL] [Abstract][Full Text] [Related]
3. Access to treatment for opioid dependence in rural America: challenges and future directions.
Sigmon SC
JAMA Psychiatry; 2014 Apr; 71(4):359-60. PubMed ID: 24500040
[No Abstract] [Full Text] [Related]
4. Methadone Access for Opioid Use Disorder During the COVID-19 Pandemic Within the United States and Canada.
Joudrey PJ; Adams ZM; Bach P; Van Buren S; Chaiton JA; Ehrenfeld L; Guerra ME; Gleeson B; Kimmel SD; Medley A; Mekideche W; Paquet M; Sung M; Wang M; You Kheang ROO; Zhang J; Wang EA; Edelman EJ
JAMA Netw Open; 2021 Jul; 4(7):e2118223. PubMed ID: 34297070
[TBL] [Abstract][Full Text] [Related]
5. A trial of implementation facilitation to increase timely admission to methadone treatment.
Gryczynski J; Mitchell SG; Whitter M; Fuller D; Mitchell MM; Edelman EJ; Schwartz RP
J Subst Use Addict Treat; 2024 Jul; 162():209375. PubMed ID: 38642889
[TBL] [Abstract][Full Text] [Related]
6. Antecedents and correlates of methadone treatment entry: a comparison of out-of-treatment and in-treatment cohorts.
Schwartz RP; Kelly SM; O'Grady KE; Mitchell SG; Brown BS
Drug Alcohol Depend; 2011 May; 115(1-2):23-9. PubMed ID: 21126830
[TBL] [Abstract][Full Text] [Related]
7. Medication-assisted recovery from opioid addiction: historical and contemporary perspectives.
White WL
J Addict Dis; 2012; 31(3):199-206. PubMed ID: 22873182
[TBL] [Abstract][Full Text] [Related]
8. A population-based examination of trends and disparities in medication treatment for opioid use disorders among Medicaid enrollees.
Stein BD; Dick AW; Sorbero M; Gordon AJ; Burns RM; Leslie DL; Pacula RL
Subst Abus; 2018; 39(4):419-425. PubMed ID: 29932847
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and current clinical practices of opioid treatment programs in the United States.
Jones CM; Byrd DJ; Clarke TJ; Campbell TB; Ohuoha C; McCance-Katz EF
Drug Alcohol Depend; 2019 Dec; 205():107616. PubMed ID: 31678836
[TBL] [Abstract][Full Text] [Related]
10. Abstinence versus agonist maintenance treatment: an outdated debate?
Uchtenhagen A
Eur Addict Res; 2013; 19(6):283-6. PubMed ID: 23651992
[No Abstract] [Full Text] [Related]
11. Correlates of specialty substance use treatment among adults with opioid use disorders.
Romo E; Ulbricht CM; Clark RE; Lapane KL
Addict Behav; 2018 Nov; 86():96-103. PubMed ID: 29551551
[TBL] [Abstract][Full Text] [Related]
12. Association of Pregnancy and Insurance Status With Treatment Access for Opioid Use Disorder.
Patrick SW; Richards MR; Dupont WD; McNeer E; Buntin MB; Martin PR; Davis MM; Davis CS; Hartmann KE; Leech AA; Lovell KS; Stein BD; Cooper WO
JAMA Netw Open; 2020 Aug; 3(8):e2013456. PubMed ID: 32797175
[TBL] [Abstract][Full Text] [Related]
13. Challenges and outcomes of parallel care for patients with co-occurring psychiatric disorder in methadone maintenance treatment.
King VL; Brooner RK; Peirce J; Kolodner K; Kidorf M
J Dual Diagn; 2014; 10(2):60-7. PubMed ID: 24976801
[TBL] [Abstract][Full Text] [Related]
14. Financial factors and the implementation of medications for treating opioid use disorders.
Knudsen HK; Roman PM
J Addict Med; 2012 Dec; 6(4):280-6. PubMed ID: 22810057
[TBL] [Abstract][Full Text] [Related]
15. Methadone Maintenance Treatment: A 15-year Retrospective Study in Split-Dalmatia County, Croatia.
Sutlovic D; Kljucevic Z; Sliskovic L; Susnjar H; Viskovic I; Definis-Gojanovic M
Ther Drug Monit; 2018 Aug; 40(4):486-494. PubMed ID: 29649094
[TBL] [Abstract][Full Text] [Related]
16. Mothers in substance abuse treatment: differences in characteristics based on involvement with child welfare services.
Grella CE; Hser YI; Huang YC
Child Abuse Negl; 2006 Jan; 30(1):55-73. PubMed ID: 16406024
[TBL] [Abstract][Full Text] [Related]
17. Sociodemographic disparities in supplemental service utilization among male methadone patients.
Wu E; El-Bassel N; Gilbert L; Piff J; Sanders G
J Subst Abuse Treat; 2004 Apr; 26(3):197-202. PubMed ID: 15063913
[TBL] [Abstract][Full Text] [Related]
18. Medicaid Coverage for Methadone Maintenance and Use of Opioid Agonist Therapy in Specialty Addiction Treatment.
Saloner B; Stoller KB; Barry CL
Psychiatr Serv; 2016 Jun; 67(6):676-9. PubMed ID: 26927578
[TBL] [Abstract][Full Text] [Related]
19. Use and misuse of opioid agonists in opioid addiction.
Modesto-Lowe V; Swiezbin K; Chaplin M; Hoefer G
Cleve Clin J Med; 2017 May; 84(5):377-384. PubMed ID: 28530896
[TBL] [Abstract][Full Text] [Related]
20. Changing patient characteristics with increased methadone maintenance availability.
Brands B; Blake J; Marsh D
Drug Alcohol Depend; 2002 Mar; 66(1):11-20. PubMed ID: 11850131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
